HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Pancreatic insufficiency — Clinical Guidelines

Overview

Pancreatic insufficiency refers to inadequate exocrine pancreatic function, leading to maldigestion and malabsorption of nutrients, often characterized by steatorrhea and deficiencies in fat-soluble vitamins 8.

Diagnosis

Clinical Presentation: Steatorrhea, abdominal pain, weight loss, and nutrient deficiencies 8.

Laboratory Tests: Fecal elastase-1 levels, fecal fat test, and serum levels of vitamins A, D, E, and K 2.

Imaging and Endoscopy: ERCP with pancreatic function tests, EUS for structural assessment 5.

Management

Pancreatic Enzyme Replacement Therapy (PERT):

- Pancrelipase: Typically dosed at 1000-2000 units of lipase per meal (adjust based on response and fat content of meals) 2.

Dietary Modifications: High-protein, low-fat diet with supplementation of fat-soluble vitamins 2.

Monitoring: Regular follow-up to assess nutritional status and adjust PERT as needed 2.

Special Populations

Radiation-Induced Insufficiency: Consider both pancreatic and enteric causes of steatorrhea post-irradiation 8.

Key Recommendations

Initiate Pancrelipase Therapy for confirmed pancreatic insufficiency to improve digestion and absorption (Evidence: Moderate 2).

Regular Follow-Up is essential to monitor response to therapy and nutritional status (Evidence: Expert opinion 2).

Consider Dual Etiology in patients with steatorrhea following abdominal irradiation, evaluating both pancreatic function and enteric causes (Evidence: Weak 8).

References

1 Canakis A, Maoz A, Tkacz JN, Huang C. Factors affecting the rates of adherence to surveillance recommendations for incidental pancreatic cystic lesions in a large urban safety net hospital. BMJ open gastroenterology 2020. link 2 Wilcock A, McGeeney L, Kidd E, Mihalyo M, Charlesworth S. Pancreatic enzymes (pancrelipase). Journal of pain and symptom management 2020. link 3 Sparmann G, Hohenadl C, Tornøe J, Jaster R, Fitzner B, Koczan D et al.. Generation and characterization of immortalized rat pancreatic stellate cells. American journal of physiology. Gastrointestinal and liver physiology 2004. link 4 Duman M, Clark A. Patient information: Part 2. Planning an information package. Professional nurse (London, England) 2003. link 5 Ahmad NA, Kochman ML, Brensinger C, Brugge WR, Faigel DO, Gress FG et al.. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointestinal endoscopy 2003. link 6 Saotome T, Inoue H, Fujimiya M, Fujiyama Y, Bamba T. Morphological and immunocytochemical identification of periacinar fibroblast-like cells derived from human pancreatic acini. Pancreas 1997. link 7 Wang CS, Kloer HU. Kinetic properties of human pancreatic carboxylesterase. Biochimica et biophysica acta 1983. link90155-8) 8 Kingham JG, Barrett A. Pancreatic insufficiency following abdominal irradiation. Postgraduate medical journal 1980. link

Pancreatic insufficiency